Updates in Colo-Proctology 1992
DOI: 10.1007/978-3-642-51680-1_15
|View full text |Cite
|
Sign up to set email alerts
|

Lymph Node Metastases in Early Rectal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“…The overall metastatic lymph node rate for ERC or T1 tumours ranges from 5·7 to 25 per cent6, 7, 79, 93–96. The rate of lymph node metastasis increases with the Kikuchi level: there is a 1–3 per cent risk with Sm1, 8 per cent with Sm2 and 23 per cent with Sm36.…”
Section: Treatment Selection For Early Rectal Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…The overall metastatic lymph node rate for ERC or T1 tumours ranges from 5·7 to 25 per cent6, 7, 79, 93–96. The rate of lymph node metastasis increases with the Kikuchi level: there is a 1–3 per cent risk with Sm1, 8 per cent with Sm2 and 23 per cent with Sm36.…”
Section: Treatment Selection For Early Rectal Cancermentioning
confidence: 99%
“…ERC is a relatively uncommon finding in Western populations. The incidence of malignant colorectal polyps as a proportion of all adenomas removed varies between 2·6 and 9·7 per cent, with an average of 4·7 per cent5; 3–8·6 per cent of all resected colorectal adenocarcinomas are stage T14, 6, 7. The incidence of ERC will rise following the start of the UK screening programme.…”
Section: Introductionmentioning
confidence: 99%
“…The presence of estrogen receptors (ERs) has been clearly demonstrated in 70% of CRCs [16]. Moreover, a number of other authors have shown that tamoxifen has a potent inhibitory action on metastatic cells from colo-rectal cancer in murine models [17]. It must be underlined that in our analysis this association is close to the inferior limits of the statistical significance and hampered by the fact that only two studies analyse this aspect (I2 : 55%).…”
Section: Discussionmentioning
confidence: 72%
“…After referring to full texts, 65 studies which did not satisfy the inclusion/exclusion criteria were removed from consideration. A total of 8 studies were left for analysis, involving a total of 1560 patients (Figure 1) [5,[13][14][15][16][17][18][19]. All 8 works were retrospective case studies of T1/T2 primary rectal cancer treated with RS and TME, ranging from 2++ to 2− according to the SIGN classification for grading evidence (Scottish Intercollegiate Guidelines Network) [13].…”
Section: Data Sourcesmentioning
confidence: 99%
“…The presence of lymph node metastases [ 53–55] strongly increases the risk of recurrence, independent of the depth of tumour invasion. Some early rectal tumours will metastasize to lymph nodes before the tumour has penetrated the rectal wall [ 56, 57]. However, extended tumour staging has been shown to influence clinical decisions in patients with rectal carcinoma [ 58], and though there have been considerable advances in preoperative tumour staging with the use of endoanal ultrasound and magnetic resonance imaging (MRI), it remains inexact [ 59].…”
Section: Factors Affecting Recurrencementioning
confidence: 99%